Emerging therapeutic targets in follicular lymphoma [Interview] Miscellaneous
| Author: | Wendel, H. G. |
| Title: | Emerging therapeutic targets in follicular lymphoma [Interview] |
| Keywords: | protein expression; unclassified drug; gene mutation; note; gene; protein bcl 2; protein p16; gene expression; protein p53; carcinogenesis; tumor suppressor gene; myc protein; initiation factor 4e; chimeric antigen receptor; chromosome translocation; cyclin dependent kinase inhibitor 2a; cytotoxic t lymphocyte antigen 4; retinoblastoma protein; initiation factor 4a; follicular lymphoma; cd19 antigen; herpesvirus entry mediator; programmed death 1 ligand 1; programmed death 1 receptor; histone lysine methyltransferase; transcription factor ezh2; e1a associated p300 protein; b lymphocyte receptor; cyclic amp responsive element binding protein binding protein; human; venetoclax; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; chimeric antigen receptor t-cell immunotherapy; b and t lymphocyte attenuator receptor |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 18 |
| Issue: | 1 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2020-01-01 |
| Start Page: | 32 |
| End Page: | 34 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Export Date: 2 March 2020 -- Source: Scopus |
MSK Authors
-
102Wendel